Chain Bridge I マネジメント

マネジメント基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Andrew Cohen

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	n/a
経営陣の平均在職期間	データなし
取締役会の平均在任期間	less than a year

経営陣の近況

Recent updates

CEO（最高経営責任者

Andrew Cohen (46 yo)

less than a year

在職期間

Mr. Andrew Cohen is CEO & Director of Chain Bridge I from January 2024. From January 2019 to September 2023 Mr. Cohen was a Founder and the CIO of Difesa Capital Management, a special situations fund focus...

取締役

名称	ポジション	在職期間	報酬	所有権
Andrew Cohen	CEO & Director	less than a year	データなし	データなし
Jeffrey Siegal	Chairman of Advisory Board	no data	データなし	データなし
Edward Sanderson	Member of Advisory Board	no data	データなし	データなし
Arun Gupta	Member of Advisory Board	no data	データなし	データなし
Rick Gustafson	Member of Advisory Board	no data	データなし	データなし
James Cacioppo	Member of Advisory Board	no data	データなし	データなし
Oliver Wiener	Independent Director	less than a year	データなし	データなし
Lewis Silberman	Independent Director	less than a year	データなし	データなし
Jeremy Bash	Member of Advisory Board	no data	データなし	データなし
Alex Younger	Member of Advisory Board	no data	データなし	データなし
Daniel Wainstein	Independent Chairman	less than a year	データなし	データなし
Paul Baron	Independent Director	less than a year	データなし	データなし

0.9yrs

平均在職期間

49.5yo

平均年齢

経験豊富なボード: CBRR.Fの取締役会は経験豊富ではない ( 0.9年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Chain Bridge I マネジメント

マネジメント基準チェック /04

主要情報

経営陣の近況

High number of new and inexperienced directors

Chain Bridge I Appoints Andrew Cohen as Chief Executive Officer

Chain Bridge I Appoints Andrew Cohen, Daniel Wainstein, Lewis Silberman and Paul Baron to the Board

High number of new and inexperienced directors

Chain Bridge I Appoints David G. Brown as Director and Member of the Audit Committee and Nominating Committee

Chain Bridge I Announces Resignation of Nathaniel Fick from the Board of Directors and as a Member of its Audit Committee, Compensation Committee and Nominating Committee

Recent updates

Chain Bridge I(OTCPK:CBRR.F) dropped from NASDAQ Composite Index

Chain Bridge I(OTCPK:CBRR.F) dropped from NASDAQ Composite Index

Chain Bridge I announced delayed 10-Q filing

Chain Bridge I to be Delisted from The Nasdaq Stock Market Due to Non-Compliance with Listing Rule IM-5101-2

Chain Bridge I announced delayed 10-Q filing

Phytanix Bio entered into a definitive business combination agreement to acquire Chain Bridge I (NasdaqCM:CBRG) from Fulton AC 1 LLC and others for $91.9 million in a reverse merger transaction.

Chain Bridge I Receives Written Notice from the Listing Qualifications Department of the Nasdaq Stock Market

New major risk - Financial position

High number of new and inexperienced directors

New minor risk - Market cap size

Chain Bridge I Appoints Andrew Cohen as Chief Executive Officer

Chain Bridge I Appoints Andrew Cohen, Daniel Wainstein, Lewis Silberman and Paul Baron to the Board

High number of new and inexperienced directors

Chain Bridge I Appoints David G. Brown as Director and Member of the Audit Committee and Nominating Committee

Chain Bridge I Announces Resignation of Nathaniel Fick from the Board of Directors and as a Member of its Audit Committee, Compensation Committee and Nominating Committee

CEO（最高経営責任者

在職期間

取締役

平均在職期間

平均年齢

Chain Bridge I マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

High number of new and inexperienced directors

Chain Bridge I Appoints Andrew Cohen as Chief Executive Officer

Chain Bridge I Appoints Andrew Cohen, Daniel Wainstein, Lewis Silberman and Paul Baron to the Board

High number of new and inexperienced directors

Chain Bridge I Appoints David G. Brown as Director and Member of the Audit Committee and Nominating Committee

Chain Bridge I Announces Resignation of Nathaniel Fick from the Board of Directors and as a Member of its Audit Committee, Compensation Committee and Nominating Committee

Recent updates

Chain Bridge I(OTCPK:CBRR.F) dropped from NASDAQ Composite Index

Chain Bridge I(OTCPK:CBRR.F) dropped from NASDAQ Composite Index

Chain Bridge I announced delayed 10-Q filing

Chain Bridge I to be Delisted from The Nasdaq Stock Market Due to Non-Compliance with Listing Rule IM-5101-2

Chain Bridge I announced delayed 10-Q filing

Phytanix Bio entered into a definitive business combination agreement to acquire Chain Bridge I (NasdaqCM:CBRG) from Fulton AC 1 LLC and others for $91.9 million in a reverse merger transaction.

Chain Bridge I Receives Written Notice from the Listing Qualifications Department of the Nasdaq Stock Market

New major risk - Financial position

High number of new and inexperienced directors

New minor risk - Market cap size

Chain Bridge I Appoints Andrew Cohen as Chief Executive Officer

Chain Bridge I Appoints Andrew Cohen, Daniel Wainstein, Lewis Silberman and Paul Baron to the Board

High number of new and inexperienced directors

Chain Bridge I Appoints David G. Brown as Director and Member of the Audit Committee and Nominating Committee

Chain Bridge I Announces Resignation of Nathaniel Fick from the Board of Directors and as a Member of its Audit Committee, Compensation Committee and Nominating Committee

CEO（最高経営責任者

在職期間

取締役

平均在職期間

平均年齢

マネジメント基準チェック /04